Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03579472 |
Title | M7824 and Eribulin Mesylate in Treating Patients With Metastatic Triple Negative Breast Cancer |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | M.D. Anderson Cancer Center |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |